Biomedicina y Biotecnología
Departamento
Hospital Universitario de la Princesa
Madrid, España
Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (8)
2025
- Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer
Laboratory Investigation, Vol. 105, Núm. 10
- Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter study
Anaesthesia Critical Care and Pain Medicine, Vol. 44, Núm. 5
2024
- Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615
2023
- Gender inequity in the medical profession: the women doctors in Spain (WOMEDS) study
Human Resources for Health, Vol. 21, Núm. 1
2022
- Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2017
- Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease
Biomarkers, Vol. 22, Núm. 2, pp. 133-144
2014
- Effect of Infliximab in oxidised serum albumin levels during experimental colitis
Biomarkers, Vol. 19, Núm. 8, pp. 693-701
2013
- Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1
Toxicology and Applied Pharmacology, Vol. 272, Núm. 3, pp. 568-578
